The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...
Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...
Host Brian Schroer, MD, interviews Sathya Areti, MD, about her case study presented at ACAAI 2025. A 4-year-old boy with recurrent intensive care unit (ICU) admissions for lower respiratory tract ...
Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...
Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...
OWENS CROSS ROADS, Ala. (WAFF) - The City of Owens Cross Roads released a statement addressing the Pathway facility. Owens Cross Roads City Council voted in November to pursue legal action toward the ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
Pathway will retain its brand and operate independently as Clearlake’s investment solutions business Pathway’s leadership team will remain intact The company was founded in 1991 Clearlake Capital ...
SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...
OWENS CROSS ROADS, Ala. (WAFF) - The Pathway Facility in Owens Cross Roads is back in the light after three girls escaped the facility on Sunday night. Owens Cross Roads town officials confirmed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results